Scheme ESI.2. Synthesis of Cy5dT-phosphoramidite. Reagents and conditions: (i) 1-[2´-(deoxy)-5´-O-(4,4´dimethoxytrityl)-β-D-erythro-pentafuranosyl]-5-(eth-1-ynyl)uridine, CuI, Pd(PPh 3 ) 4 , Et 3 N, DMF, rt, 26 h, 91 %; (ii) 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite, DIPEA, DCM, rt, 1 h 45 min, 84 %.
Supporting Information
.1 and ESI.2) shows that the duplexes containing the CydT monomers still adopt the B-DNA conformation. Ten successive spectra were recorded and averaged. Unmodified control (black), Cy3dT and Cy5 dT in the same strand (red), Cy3dT and Cy5dT in opposite strands (green), Cy5dT control (blue) and Cy3dT control (pink). Where I FRET is the emission intensity of the Cy5 peak when excited via FRET (ex 530 nm), I direx is the emission intensity of the Cy5 peak when directly excited (ex 615 nm), Abs 615 is the absorbance of the sample at 615 nm and Abs 530 is the absorbance of the sample at 530 nm. . An increase in dye separation from 4 to 7 nucleotides and also from 12 to 14 takes the dyes further from one another both along and around the helix axis.
In contrast, an increase in dye separation from 8 to 11 nucleotides results in an increase in distance along the helical axis which is counteracted by a decrease in distance around the helical axis. These schematic representations qualitatively fit the data plotted in Figure ESI 1 H NMR spectra were measured on a Bruker AC300 spectrometer at 300 MHz or Bruker DPX400 spectrometer at 400 MHz. 13 C spectra were measured at 75 or 100 MHz respectively. 31 P spectra were measured at 121 MHz. All shifts were referenced to the residual solvent peak and are given in ppm (1). J coupling values are correct to 0.5 Hz. Assignment was aided by DEPT-135, 1 H-1 H COSY, HMQC and HMBC experiments. Experiments were carried out using CDCl 3 , d 6 -DMSO, CD 3 OD or CD 3 CN. Low-resolution mass spectra were measured on a Waters ZMD quadrupole mass spectrometer for +/electrospray ionisation (ESI). These were carried out in HPLC grade MeOH or MeCN.
High-resolution mass spectra were recorded in MeOH or MeCN on a Bruker APEX III FT-ICR mass spectrometer (ESI) or a VG Analytical 70-250-SE mass spectrometer (EI). Melting points were determined on a Gallenkamp Electrothermal melting point apparatus.
Common procedures including tritylation (2), palladium cross-coupling (3, 4) , trimethylsilyl deprotection (5, 6) and phosphitylation (7) were based on literature procedures. I-Cy5 was synthesised according to the literature (8) . 1-[2´-(deoxy)-5´-O-(4,4´-dimethoxytrityl)-β-Derythro-pentafuranosyl]-5-(eth-1-ynyl)uridine was prepared according to the published procedures (9, 10) . Quantities of reagents are quoted to either 3 significant figures or 2 decimal places as appropriate.
ESI.2.2.2. Synthetic procedures

Synthesis of 2´-Deoxy-5´-O-(4,4´-dimethoxytrityl)-5-iodouridine (11)
5-Iodo-2´-deoxyuridine (10.2 g, 28.9 mmol) was co-evaporated with distilled pyridine (3 x 10 mL) and dissolved in distilled pyridine (80 mL). To this was added drop-wise a solution of DMTCl (9.79 g, 28.9 mmol) in distilled pyridine (50 mL) over a period of 20 min and the reaction was stirred at rt for 3 h. An additional 0.2 eq DMTCl was added and the reaction stirred for a further 2.5 h. The reaction was quenched by the addition of MeOH (80 mL) and was stirred for 20 min. Characterisation data recorded matches previously reported literature values (11) .
Synthesis of 2´-Deoxy-5´-O-(4,4´-dimethoxytrityl)-5-(trimethylsilyl eth-1-ynyl)uridine
To a mixture of 2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-5-iodouridine (1. 19 
Synthesis of 2´-Deoxy-5´-O-(4,4´-dimethoxytrityl)-5-(eth-1-ynyl)uridine
To a solution of 2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-5-(trimethylsilyl eth-1-ynyl)uridine (0.11 g, 0.17 mmol) in distilled THF (2 mL) under an argon atmosphere was added 1 M TBAF in THF (0.26 mL, 0.25 mmol) and the reaction was stirred at rt for 20 min. The reaction was partitioned between EtOAc (100 mL) and brine (100 mL). The organic phase was washed with brine and dried (Na 2 SO 4 ). The solvent was removed in vacuo and the product (0.09 g, 0.17 mmol, 99 %) was afforded as a light yellow/brown foam. 
Synthesis of 5-iodo-2,3,3-trimethyl-3H-indole
To a solution of 4-iodophenylhydrazine (1.51 g, 6.46 mmol) in AcOH (120 mL) was added 3-methyl-2-butanone (0.75 mL, 7.05 mmol) and the reaction was stirred at reflux for 2.5 h. The reaction mixture was allowed to cool to rt, diluted with H 2 O (300 mL) and washed with DCM (2 x 200 mL). The organic phase was collected and concentrated in vacuo. The oily residue was diluted with DCM (16 mL). The product was extracted by addition of hexane (300 mL) which was decanted from the resultant purple oily precipitate. The yellow hexane layer was dried in vacuo to afford the product 1 (1.48 g, 5.19 mmol, 81 %) as an orange oil. Characterisation data recorded matches previously reported literature values (12) .
Synthesis of 5-iodo-1-ethyldioxolane-3,3-dimethyl-2-methyleneindoline
To a suspension of KI (15.4 g, 92.7 mmol) in distilled MeCN (60 mL) under an argon atmosphere was added bromoethyldioxolane (7.25 mL, 61.7 mmol) and the yellow suspension was stirred at 50 °C for 1 h. 5-Iodo-2,3,3-trimethylindolenine 1 (8.33 g, 29.2 mol) was added in distilled MeCN (20 mL) and the reaction was stirred at reflux for 45 h. The reaction was allowed to cool to rt and the precipitate was removed by filtration (KBr). The solvent was removed in vacuo and following purification by column chromatography (DCM with 0.5 % Et 3 N), the product was afforded as a brown oil (3.28 g, 8.52 mmol, 29 %). 
Synthesis of 1-ethyldioxolane-2,3,3-trimethylindolenine
To a suspension of KI (3.98 g, 0.02 mol) in distilled MeCN (20 mL), under an argon atmosphere, was added bromoethyldioxolane (1.55 mL, 13.2 mmol) and the yellow suspension was stirred at 50 °C for 1 h. 2,3,3-Trimethylindolenine (2 mL, 12.0 mmol) was added and the reaction stirred at reflux for 45 h. The reaction was allowed to cool to rt and filtered to remove KBr salt. The solvent was removed in vacuo and purified by column chromatography (twice in 100 % DCM with 0.5 % Et 3 N) to afford the product 4 (1.73 g, 6.68 mmol, 56 %) as an orange oil. 
Synthesis of 2-[(E)-2-(phenylamino)vinyl]-1-ethyldioxolane-,3,3-dimethyl-3H-indolium iodide
To a solution of 1-ethyldioxolane-3,3-dimethyl-2-methyleneindoline 4 (0.21 g, 0.82 mmol) in EtOH (2 mL), under an argon atmosphere, was added N,N´-diphenylformamidine (0.16 g, 0.82 mmol) and triethylorthoformate (0.14 mL, 0.82 mmol) and the reaction refluxed at high temperature (97 °C) in the dark for 16 h. The reaction solvent was removed in vacuo and following purification by column chromatography (DCM with 0.5 % Et 3 N) the product 5 (0.26 g, 0.53 mmol, 65 %) was isolated as an orange foam. 
LRMS [ESI+, MeCN
Synthesis of 5-iodo-1-ethyldioxolane-3,3-dimethyl-2-((1E,3E)-3-(1-ethyldioxolane-3,3dimethylindolin-2-ylidene)prop-1-enyl)-3H-indolium iodide
To a solution of 2-[(E)-2-(phenylamino)vinyl]-1-ethyldioxolane-3,3-dimethyl-3H-indolium iodide 5 (0.35 g, 0.72 mmol) in distilled pyridine (8 mL) was added 5-iodo-1ethynyldioxolane-3,3-dimethyl-2-methyleneindoline 2 (0.55 g, 1.44 mmol) and Ac 2 O (0.68 mL, 7.18 mmol) and the reaction was stirred under an argon atmosphere in the dark at 50 °C for 24 h. The reaction solvent was removed in vacuo and the crude material was purified by column chromatography (MeOH/EtOAc, 5:95with 0.1 % pyridine → DCM with 0.1 % pyridine) to afford the product 6 (0.45 g, 0.58 mmol, 79 %) as a dark red solid. 
Synthesis of 5-iodo-Cy3B 7 (13)
To a solution of 5-iodo-1-ethyldioxolane-3,3-trimethyl-2-((1E,3E)-3-(1-ethyldioxolane-3,3trimethylindolin-2-ylidene)prop-1-enyl)-3H-indolium iodide 6 (0.58 g, 0.74 mmol) in CHCl 3 (58 mL) was added 50 % aq. H 2 SO 4 (12 mL) and the mixture was stirred vigorously for 20 min. The reaction mixture was diluted with CHCl 3 (60 mL) and washed with H 2 O (3 x 60 mL). The aqueous phases were combined, washed with CHCl 3 (2 x 60 mL) and the combined organic phase was dried (Na 2 SO 4 ) then the solvent was removed in vacuo to afford the product 7 (0.48 g, 0.71 mmol, 96 %) as a dark pink solid. 
Synthesis of Cy3B-dT
To a mixture of 5-iodo-Cy3B 7 (0.48 g, 0.71 mmol), 2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-5-(eth-1-ynyl)uridine (0.59 g, 1.06 mmol) and CuI (0.03 g, 0.14 mmol) in anhydrous DMF (4 mL), under an argon atmosphere, was added distilled Et 3 N (2.5 mL) and the reaction was stirred for 10 min. Pd(PPh 3 ) 4 (0.08 g, 0.07 mmol) was added and the solution was stirred in the dark for 1.5 h. The reaction mixture was diluted with DCM (100 mL) and washed with 5 % aq. disodium EDTA (100 mL). The organic phase was evaporated to dryness in vacuo and purified by column chromatography (DCM to MeOH/DCM, 1:9 with 0.1 % pyridine) affording the product 8 (0.33 g, 0.30 mmol, 42 %) as a dark pink solid. 
Synthesis of Cy3B-dT-phosphoramidite
Cy3B-dT 8 (0.67 g, 0.61 mmol) was co-evaporated with distilled pyridine (3 x 5 mL) and distilled DCM (3 x 5 mL) then dissolved in distilled DCM (6 mL), with activated molecular sieves (3 Å), under an argon atmosphere. Distilled DIPEA (0.29 mL, 1.53 mmol) was added followed by 2-cyanoethyl N,N-diisopropyl-chlorophosphoramidite (0.15 mL, 0.67 mmol) drop-wise and the reaction stirred at rt for 45 min. The reaction was diluted with distilled DCM (10 mL) and washed with deoxygenated sat. aq. KCl (20 mL). The organic phase was dried (Na 2 SO 4 ) and the solvent was removed in vacuo. The crude product was precipitated 3 times consecutively in deoxygenated hexane (3 x 100 mL) from a minimum of distilled DCM (2 mL). The product was co-evaporated with distilled DCM (5 mL) and trace solvents removed in vacuo to afford the product A (0.50 g, 0.38 mmol, 63 %) as a dark pink solid. 
Synthesis of 5-(hexyn-1-ol)-6-Cy3B
To a solution of 5-iodo-Cy3B 7 (0.50 g, 0.70 mmol) and CuI (0.03 g, 0.14 mmol) in anhydrous DMF (3.5 mL), under an argon atmosphere, was added distilled Et 3 N (2.5 mL) and 5-hexyn-1-ol (0.08 mL, 0.70 mmol) and the reaction was stirred in the dark at rt for 10 min. Pd(PPh 3 ) 4 (0.08 g, 0.07 mmol) was added and the solution stirred for 3.5 h. An additional portion of 5-hexyn-1-ol (0.07 mL) was added and the reaction stirred for a further 1.5 h. The reaction was diluted with DCM (40 mL) and washed with 5 % aq. disodium EDTA (3 x 50 mL) and 5 % aq. KI solution (2 x 50 mL). The organic phase was dried (Na 2 SO 4 ) and the solvent was removed in vacuo. The crude product was dissolved in DCM (2 mL), filtered through celite and precipitated in hexane (100 mL). The material was filtered through alumina and trace solvents were removed in vacuo to afford the product 9 (0.37 g, 0.57 mmol, 82 %) as a deep pink solid. 5-(Hexyn-1-ol)-6-Cy3B 9 (0.35 g, 0.54 mmol) was co-evaporated with distilled pyridine (5 mL) and distilled DCM (3 x 5mL) then dissolved in distilled DCM (5 mL), with activated molecular sieves (3 Å), under an argon atmosphere. To this was added distilled DIPEA (0.24 mL, 1.35 mmol) followed by 2-cyanoethyl N,N-diisopropyl-chlorophosphoramidite (0.13 mL, 0.60 mmol) and the reaction was stirred at rt for 45 min. The reaction was diluted with distilled DCM (10 mL) and washed with deoxygenated sat. aq. KCl (10 mL) then dried (Na 2 SO 4 ). The solvent was removed in vacuo then the crude material was purified by precipitation in deoxygenated hexane (150 mL) from a minimum of distilled DCM (2 mL). The precipitation was repeated a further two times. The precipitate was co-evaporated with distilled DCM (3 mL) and trace solvents were removed under high vacuum to afford the product B (0.42 g, 0.50 mmol, 93 %) as a purple foam. 
LRMS [ESI+, MeCN
Synthesis of 5-trimethylsilylethynyl-Cy3B
To a solution of 5-iodo-Cy3B 7 (0.29 g, 0.43 mmol) and CuI (0.02 g, 0.09 mmol) in anhydrous DMF (2.5 mL), under an argon atmosphere was added distilled Et 3 N (1.5 mL) and trimethylsilylacetylene (0.09 mL, 0.64 mmol) and the reaction was stirred at rt for 10 min. Pd(PPh 3 ) 4 (0.05 mg, 0.04 mmol) was added and the reaction was stirred for 16 h. The reaction was diluted with DCM (100 mL) and washed with 5 % aq. disodium EDTA solution (100 mL) and 5 % aq. sat. KI solution (100 mL). The organic phase was dried (Na 2 SO 4 ) and the solvent was removed in vacuo. Following purification by column chromatography (7 M NH 3 :MeOH/DCM, 1:99 up to 1:9), the product 10 (0.20 g, 0.31 mmol, 71 %) was afforded as a purple iridescent solid. 
Synthesis of 5-ethynyl-Cy3B
To a solution of 5-trimethylsilylethynyl-Cy3B 10 (0.13 g, 0.20 mmol) in distilled THF (3 mL), under an argon atmosphere, was added 1 M TBAF in THF (0.31 mL, 0.31 mmol) and the reaction was stirred for 5 min at rt. The reaction was diluted with DCM (100 mL) and washed with H 2 O (2 x 500 mL) and 5 % aq. sat. KI solution (250 mL). The organic phase was dried (Na 2 SO 4 ), the solvent removed in vacuo and the crude material purified by column chromatography (7M NH 3 :MeOH/DCM, 1:99) to afford the product E (0.09 g, 0.16 mmol, 75 %) as a purple iridescent solid. 
Synthesis of 1´-α-chloro-2´-deoxy-3,5-di-O-p-toluoyl-D-ribose (14)
To a solution of 2´-deoxy-D-ribose (10.0 g, 74.5 mmol) in MeOH (120 mL) was added 1 % methanolic HCl (20 mL: made by adding 1.7 mL acetyl chloride to 100 mL MeOH). The resulting yellow solution was stirred for 30 min. The reaction was neutralised by the addition of solid sodium bicarbonate (4.0 g). The solid was removed by filtration, washed with MeOH and the filtrate was evaporated. Residual MeOH was removed by co-evaporation with distilled pyridine (1 x 50 mL, 2 x 25 mL) and the golden coloured syrup was dried under high vacuum for 2.5 h. To the residue, dissolved in distilled pyridine (60 mL), cooled to 0 °C, was added p-toluoylchloride (22.0 mL, 160 mmol) drop-wise. The cloudy solution was stirred at rt for 16 h. The reaction was diluted with cold water (150 mL) and extracted with DCM (1 x 150 mL, 2 x 100 mL).The organic phase was washed with NaHCO 3 (2 x 150 mL), 2 M HCl (150 mL) and H 2 O (200 mL), then dried (Na 2 SO 4 ) and the solvent was removed in vacuo. To the oil (30.8 g) dissolved in AcOH (40 mL) at 0 °C, was slowly added sat. HCl in AcOH (63 mL; prepared by adding 16.3 mL acetyl chloride to a mixture of cold AcOH, 81 mL, and water, 4 mL). An additional amount of acetyl chloride (7 mL) was added and the flask was swirled for 10 min resulting in the formation of a thick crystalline precipitate. The precipitate was rapidly filtered and washed thoroughly with cold anhydrous Et 2 O (prepared over molecular sieves, 3 Å). Following drying in vacuo the product 14 (18.7 g, 48.1 mmol, 64 %) was afforded as a white solid, which was stored under argon. Characterisation data recorded matches previously reported literature values (14) . 
Synthesis of 1-α/β-O-hexyne-2´-deoxy-3,5-di-O-p-toluoyl-D-ribose
Synthesis of 1-α/β-O-hexyne-2´-deoxy-D-ribose
Synthesis of 1´-α/β-O-hexyne-5´-O-(4,4´-dimethoxytrityl)-2´-deoxy-D-ribose
1-α/β-O-Hexyne-2´-deoxy-D-ribose 16 (1.51 g, 7.06 mmol) was co-evaporated with distilled pyridine (3 x 10 mL) and dissolved in distilled pyridine (20 mL) under an argon atmosphere.
To the solution was added DMAP (0.17 g, 1.40 mmol). A solution of DMTCl (3.59 g, 10.6 mmol, in 15 mL distilled pyridine) was added drop-wise over 20 min and the reaction was stirred at rt for 1 h. MeOH (20 mL) was added to quench the reaction and the solution was stirred for 30 min. The reaction volume was reduced by half in vacuo, diluted with DCM (100 mL) and washed with H 2 O (100 mL) and NaHCO 3 (2 x 100 mL). The organic phase was dried (Na 2 SO 4 ) and the solvent removed in vacuo. Following purification by column chromatography (EtOAc/ Pet ether, 1:4 with 0.1 % pyridine) the separated anomeric products, 17α (1.68 g, 3.25 mmol, 47 %) and 17β (1.51 g, 2.92 mmol, 41 %), were afforded as colourless oils in a total of 88 % yield. The assignment of the anomers was accomplished by NMR experiments (including NOE) and by agreement with literature data of α-nucleosides (15) and with above reported βnucleoside NMR data.
Synthesis of 2´-deoxyribose-1´-α-hexynyl-Cy3B (α-Cy3BdR)
To 1´-α-O-hexyne-5´-O-(4,4´-dimethoxytrityl)-2´-deoxy-D-ribose 17α (1g, 1.93 mmol) was added 5-iodo-Cy3B 7 (1.3 g, 1.93 mmol) and CuI (74 mg, 0.386 mmol) in anhydrous DMF (10 mL) under an argon atmosphere. To this, distilled Et 3 N (7 mL) was added and the reaction was stirred for 10 min in the dark at rt. Pd(PPh 3 ) 4 (0.22 g, 0.19 mmol) was added and the reaction was stirred for 52 h. The reaction was diluted with DCM (200 mL) and washed with 5 % aq. disodium EDTA (2 x 200mL) and 5 % aq. sat. KI solution (200 mL). The organic phase was dried (Na 2 SO 4 ) and the solvent removed under high vacuum. Following purification by column chromatography (twice in 7 M NH 3 :MeOH/DCM, 1:9) the product, 18α (1.37 g, 1.29 mmol, 66 %) was afforded as a purple foam. 
Synthesis of 2´-deoxyribose-1´-β-hexynyl-Cy3B (β-Cy3BdR)
This was prepared using the procedure as detailed above for 18α from 1´-β-O-hexyne-5´-O-(4,4´-dimethoxytrityl)-2´-deoxy-D-ribose 17β (1g, 1.93 mmol) to give the product 18β (1.51 g, 1.42 mmol, 73 %) as a purple foam. 
Synthesis of β-Cy3BdR phosphoramidite
2´-Deoxyribose-1´-β-hexynyl-Cy3B (β-Cy3BdR) 18β (0.50 g, 0.47 mmol) was co-evaporated with distilled pyridine (3 x 5 mL) and distilled DCM (3 x 5 mL) then dissolved in distilled DCM (2 mL), with activated molecular sieves (3 Å), under an argon atmosphere. To this was added distilled DIPEA (0.20 mL, 1.18 mmol) and the reaction was stirred for 10 min. 2-Cyanoethyl N,N-diisopropyl-chlorophosphoramidite (0.13 mL, 0.56 mmol) was added drop-wise and the reaction was stirred for 45 min. The reaction mixture was diluted with distilled DCM (10 mL) and washed with deoxygenated sat. KCl (10 mL). The organic phase was dried (Na 2 SO 4 ) and the solvent was removed in vacuo. The crude material was precipitated in deoxygenated hexane (100 mL) from a minimum of distilled DCM (1 mL). The precipitation procedure was repeated twice and the final precipitate was co-evaporated with distilled DCM (2 mL) and trace solvents were removed in vacuo affording the product C (0.56 g, 0.44 mmol, 94 %) as a dark pink iridescent solid. The resin used for coupling was AminoSynBase 1000 Å (loading 59 µmol/g) purchased from Link Technologies. All steps were carried out under argon using dry solvents.
Resin (250 mg, 0.015 mmol) was activated by washing with 3 % TCA in DCM (3 mL) and suspending in 3 % TCA in DCM (3 mL) for 4 h at rt. The TCA was removed by filtration and the resin was washed with Et 3 N:DIPEA (9:1) (3 x 3 mL), DCM (3 x 3 mL) and Et 2 O (3 x 3 mL). The resin was dried under high vacuum for 1 h then soaked in pyridine (2 mL) for 10 min. To the suspension were added succinic anhydride (112 mg, 1.10 mmol) and 4-DMAP (23.0 mg, 0.189 mmol) in pyridine (2 mL) under an argon atmosphere and the vessel was rotated at rt for 20 h. The reaction solvent was removed and the resin was washed with pyridine (3 x 3 mL), DCM (3 x 3 mL) and Et 2 O (3 x 3 mL). The resin was dried under high vacuum for 1 h before soaking in pyridine (3 mL) for 10 min. This was removed and a solution of EDC (46.0 mg, 0.30 mmol), 4-DMAP (2.0 mg, 0.015 mmol), Et 3 N (0.01 mL) and 2´-deoxyribose-1´-α-hexynyl-Cy3B (α-Cy3BdR) 39α (60.0 mg, 0.056 mmol) in pyridine (3 mL) was added. The vessel was rotated under argon for 20 h at rt. Pentachlorophenol (20.0 mg, 0.07 mmol) was added to the existing mixture which was rotated for a further 3 h. The solvent was removed and the resin was washed with pyridine (3 x 3 mL), DCM (3 x 3 mL) and Et 2 O (3 x 3 mL). To the resin was added piperidine (10 % in DMF, 3 mL) and the vessel was rotated for 1.5 min. The solvent was rapidly removed and the resin washed with DCM (3 x 3 mL), Et 2 O (3 x 3 mL) and THF (3 x 3 mL). Capping reagent (Ac 2 O/pyridine/THF:N-methylimidazole 1:1, 2 mL) was added and the vessel was rotated for 1 h. The solution was removed and the resin was washed with THF (3 x 3 mL), pyridine (3 x 3mL), DCM (3 x 3 mL) and Et 2 O (3 x 3 mL) before drying in vacuo to afford the resin D with a loading of 13 µmol/g. Loading was calculated by the trityl yield method (16) . -1,2,3,3-tetramethyl-3H-indolium iodide (18,19) To a solution of 5-iodo-2,3,3-trimethyl-3H-indole 1 (1.42 g, 4.99 mmol) in MeCN (10 mL) was added MeI (0.34 mL, 5.44 mmol) and the reaction was stirred under reflux for 16 h. The reaction mixture was allowed to cool to rt and the orange precipitate was collected by filtration, washed with Et 2 O and the solvent removed in vacuo to afford the product 19 (1.67 g, 3.91 mmol, 78 %) as a light orange powder. Characterisation data recorded matches previously reported literature values (18, 19) .
Synthesis of 5-iodo
Synthesis of 2-[(E)-2-(phenylamino)vinyl]-5-iodo-1,3,3-trimethyl-3H-indolium iodide (experimental method based on literature (20))
To a mixture of 5-iodo-1,2,3,3-tetramethyl-3H-indolium iodide 19 (1.10g, 2.58 mmol) and N,N´-diphenylformamidine (0.51g, 2.58 mmol) in ethanol (10 mL) was added triethylorthoformate (0.43 mL, 2.58 mmol) and the reaction was heated under reflux for 2.5 h.The mixture was allowed to cool to rt, the solvent removed in vacuo and the residue resuspended in ice-cold CHCl 3 . The resulting orange precipitate was filtered and washed with ice-cold CHCl 3 . A further 2 isolations of precipitate were made from the filtrate by repeating the procedure, affording the product 20 (1.30 g, 2.45 mmol, 95 %) as an orange powder. 
Synthesis of 5-iodo-1,3,3-trimethyl-2-((1E,3E)-3-(1,3,3-trimethylindolin-2-ylidene)prop-1-enyl)-3H-indolium iodide (5-iodo-Cy3) (18)
To a mixture of 2-[(E)-2-(phenylamino)vinyl]-5-iodo-1,3,3-trimethyl-3H-indolium iodide 19 (1.88g, 3.54 mmol) and 1,2,3,3-tetramethyl-3H-indolium iodide (1.07 g, 3.54 mmol) in distilled pyridine (20 mL) was added Ac 2 O (0.67 mL, 7.09 mmol) and the reaction was stirred at 50 °C for 24 h. Additional portions of 1,2,3,3-tetramethyl-3H-indolium iodide (0.43g, 1.42 mmol) and Ac 2 O (1.11 mL, 11.9 mmol) were added to the reaction and it was stirred at 50 °C for a further 24 h. The mixture was allowed to cool to rt and the addition of Et 2 O (20 mL) afforded a brown precipitate. The precipitate was isolated by filtration and following purification by column chromatography (DCM to MeOH/DCM, 5:95) the product 21 (1.31 g, 2.15 mmol, 61 %) was afforded as a dark purple solid. Characterisation data recorded matches previously reported literature values (18) .
Synthesis of Cy3dT
To a mixture of 5-iodo-Cy3 21 (1.24 g, 2.03 mmol), 2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-5-(eth-1-ynyl)uridine (1.24 g, 2.23 mmol) and CuI (0.08 g, 0.41 mmol) in anhydrous DMF (10 mL) under an argon atmosphere was added distilled Et 3 N (7 mL) and the mixture stirred for 10 min at rt. Pd(PPh 3 ) 4 (0.24 g, 0.20 mmol) was added and the reaction stirred at rt in the dark for 24 h. The reaction solvent was removed in vacuo. Following purification by column chromatography ([1] MeOH/DCM, 5:95 with 1 % pyridine. [2] EtOH/EtOAc, 1:9 to 2:8 with 1 % pyridine. [3] MeOH/DCM, 1:9 with 1 % pyridine) the product 22 (0.88 g, 0.85 mmol, 42 %) was afforded as a purple/gold iridescent solid. 
Synthesis of Cy3dT-phosphoramidite
Cy3dT 22 (0.63 g, 0.61 mmol) was co-evaporated with distilled pyridine (3 x 5 mL) and distilled DCM (5 x 5 mL) before suspending in distilled DCM (10 mL), with activated molecular sieves (3 Å), under an argon atmosphere. To this was added distilled DIPEA (0.27 mL, 1.53 mmol) followed by the drop-wise addition of 2-cyanoethyl N,N-diisopropylchlorophosphoramidite (0.14 mL, 0.61 mmol) and the reaction was stirred at rt for 45 min. An additional portion of 2-cyanoethyl N,N-diisopropyl-chlorophosphoramidite (0.1 eq) was added and the reaction stirred for a further 2 h. The solution was diluted with distilled DCM (10 mL) and washed with deoxygenated aq. sat. KCl (20 mL). The organic phase was dried (Na 2 SO 4 ) and the solvent removed in vacuo before purification by precipitation in deoxygenated hexane (250 mL) from a minimum of DCM (2 mL). The precipitation process was repeated twice. The precipitate was dried in vacuo to afford the product F (0.73 g, 0.59 mmol, 96 %) as a dark pink solid. 
Synthesis of Cy5dT
To a mixture of iodo-Cy5 (1.00 g, 1.47 mmol), 2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-5-(eth-1-ynyl)uridine (1.50 g, 2.70 mmol) and CuI (0.06 g, 0.29 mmol) in anhydrous DMF (7.5 mL) under an argon atmosphere was added distilled Et 3 N (5.2 mL) and the mixture stirred at rt for 10 min. Pd(PPh 3 ) 4 (0.17 g, 0.15 mmol) was added and the reaction stirred at rt in the dark for 24 h. Additional CuI (0.2 eq) and Pd(PPh 3 ) 4 (0.1 eq) were added and the reaction stirred at rt for a further 2 h. The reaction solvent was removed in vacuo and the product purified by column chromatography ([1] MeOH/DCM, 2:8 with 1 % pyridine. [2] EtOH/EtOAc, 3:7 with 1 % pyridine) to afford the product 23 (1.49 g, 1.35 mmol, 91 %) as a blue/red iridescent solid. 
Synthesis of Cy5dT-phosphoramidite
Cy5dT 23 (0.24 g, 0.22 mmol) was co-evaporated with distilled pyridine (3 x 5 mL) followed by distilled DCM (5 x 5 mL) before suspending in distilled DCM (5 mL), with activated molecular sieves (3 Å), under an argon atmosphere. To the solution was added distilled DIPEA (0.10 mL, 0.55 mmol). 2-Cyanoethyl N,N-diisopropyl-chlorophosphoramidite (0.05 mL, 0.22 mmol) was added drop-wise and the reaction was stirred for 45 min. Additional 2-cyanoethyl N,N-diisopropyl-chlorophosphoramidite (0.1 eq) was added before stirring for a further 1 hour. The mixture was diluted with distilled DCM (10 mL) and washed with deoxygenated aq. sat. KCl (10 mL). The organic phase was dried (Na 2 SO 4 ) and the solvent removed in vacuo. The crude product was purified by precipitation in deoxygenated hexane (50 mL) from a minimum of distilled DCM (2 mL). The precipitation procedure was repeated twice more. The precipitate was dried in vacuo to afford the product G (0.24 g, 0.18 mmol, 84 %) as a dark blue solid. 
ESI.3. Oligonucleotide synthesis and purification
DNA reagents including standard DNA phosphoramidites and solid supports were purchased from Link Technologies Ltd. Oligonucleotides were synthesised on an Applied Biosystems 394 automated DNA/RNA synthesiser. Phosphoramidite cycles, including acid-catalysed detritylation, coupling, capping and iodine oxidation steps, were undertaken in 0.2 or 1.0 µmole scale. Standard DNA phoshoramidites were used for the majority of oligonucleotide sequences, however fast-deprotecting monomers, dmf-dG and Ac-dC, were used for those sequences containing Cy5dT. Coupling efficiencies and overall oligonucleotide yields were determined by the automated trityl cation conductivity monitoring facility of the synthesiser and were ≥98.0 % for all cases. Phosphoramidite monomers were dissolved in anhydrous acetonitrile to a concentration of 0.1 M immediately prior to use. The coupling time for A, G, C and T monomers was set to 25 s, however, the coupling time for the modified monomers was extended to 360 s. The cleavage of oligonucleotides from the solid support and subsequent deprotection was undertaken by suspending the resin in concentrated aqueous ammonia for 60 min at rt followed by heating in a sealed tube for 5 h at 55 °C. For oligonucleotides containing Cy5dT the deprotection time was reduced to 1 h at 55 °C. A Gilson HPLC system with ABI Aquapore C8 column (8 mm x 250 mm, pore size 300 Å) was used to purify the oligonucleotides by reversed-phase. The following protocol was used for the majority of oligonucleotides: run time 20 min, flow rate 4 mL per min, gradient: time in min (% buffer B);0 (0); 3 (0); 3.5 (25); 15 (70); 16 (100); 17 (100); 17.5 (0); 20 (0). For the hydrophobic Cy3B oligonucleotides a modified protocol was used: run time 25 min, flow rate 4 mL per min, gradient: time in min (% buffer B); 0 (0); 3 (0); 3.5 (15); 15 (60); 16 (100); 22 (100); 22.5 (0); 25 (0). Elution buffer A: 0.1 M ammonium acetate, pH 7.0, buffer B: 0.1 M ammonium acetate with 50 % acetonitrile pH 7.0. Elution of the oligonucleotides was monitored by ultraviolet absorption at 295 nm and the main peak was collected then desalted using NAP-10 gel filtration columns (GE Healthcare), aliquoted into eppendorf tubes and stored at -20 ºC. All oligonucleotides were characterised either by MALDI-TOF mass spectrometry or MicrOTOF electrospray mass spectrometry and capillary gel electrophoresis.
ESI.4. Biophysical studies
ESI.4.1 UV analysis
ESI.4.1.1 Extinction coefficient calculation
Measurements were made on a Cary 4000 UV-Vis spectrometer with Cary temperature controller using Cary Win UV Scan software. Extinction coefficients of compounds (in MeOH or EtOH) were calculated from four readings of UV absorbance at the UV absorbance maxima using the Beer-Lambert law, A=εcl (where A is absorbance at UV A max , c is concentration in M, l is pathlength 1 cm and ε is extinction coefficient M -1 cm -1 ). Samples were analysed in a 1 mL cuvette (Hellma synthetic quartz 'precision cell QG'; 1 mL volume, 10 mm pathlength). In the case of the CyDyes, samples were dissolved in EtOH and passed through Dowex-1chloride (Dowex 1x2-200 ion exchange resin) to convert all counter ions to Cl -. Samples were then dried in a heating pistol over P 2 O 5 at 50 ºC for 48 h before a stock solution was prepared of each (1 mg / 10 mL MeOH). Compounds were diluted from the stock solution to give four readings below an absorbance value of 1. Absorbance values were plotted against concentration and a straight line was drawn through the points intercepting the Y-axis at 0. The extinction coefficient was taken as the gradient of the line.
ESI.4.1.2 UV Melting Analysis
Measurements were made on a Cary 4000 UV-Vis spectrometer with Cary temperature controller. Cary Win UV Thermal software was used with an absorption wavelength of 260 nm. Samples were analysed in 1 mL cuvettes (Hellma synthetic quartz 'precision cell QG'; 1 mL volume, 10 mm pathlength) and were made to 1 μM oligonucleotide concentration in phosphate buffer (10 mM) with NaCl (100 mM) at pH 7. Three successive melting curves were measured, and average T m values were calculated with Cary Win UV Thermal application software. The thermal protocol used was as follows: Start T 20 °C, end T 20 °C. 
ESI.4.1.3 Circular Dichroism Analysis
Circular dichroism spectra were recorded on a Jasco J-720 spectropolarimeter. Samples were made to 1 μM oligonucleotide concentration in phosphate buffer (10 mM) with NaCl (100 mM) at pH 7. Spectra were recorded between 200-320 nm at a rate of 100 nm/min, with step resolution of 0.2 nm, bandwidth of 1.0 nm and sensitivity of 50 mdeg. Ten successive spectra were recorded and an average was taken. A blank (buffer) baseline was subtracted from each spectrum.
ESI.4.2 Fluorescence analysis
ESI.4.2.1 Fluorescence melting analysis
For single-wavelength analysis, measurements were made on a Perkin Elmer LS50B fluorimeter equipped with a Perkin Elmer PTP-1 Peltier system. FLWinlab TempScan software was used with optimum excitation/emission slit widths, excitation wavelength and emission wavelength settings for each individual sample. In cases where multiple samples were compared, the slit width and excitation wavelength settings were kept constant. Where multiple dyes were compared, excitation wavelength was taken as the absorption maxima or ¾ absorbance maxima as specified in experimental discussion.
Samples were analysed in a 200 µL cuvette (Hellma quartz 'SUPRASIL QS'; 200 µL volume, 10 mm pathlength) with a collection angle of 90°. A total sample volume of 200 μL was used, with labelled oligonucleotide concentration of 0.15 μM (0.5 μM for target strand, or 0.15 µM in cases where target strand was also dye-containing). Samples were prepared in GoTaq colourless PCR buffer (Promega) with a total of 3 mM MgCl 2 at pH 8.5. The oligonucleotide samples were heated to 70 °C to denature for 3 min before being allowed to slowly cool to rt to anneal.
Samples were heated from 30 °C to 80 °C with a step size of 1 °C and 30 s equilibration.The emission intensity was recorded at each step.
For fixed-wavelength analysis, fluorescence melting was carried out using a RotorGene-3000 with settings of excitation 530 nm and detection 585 nm with a gain of 5. Samples were analysed in RotorGene thin-walled PCR tubes (0.1 mL. Qiagen). A total sample volume of 20 μL was used, with labelled oligonucleotide concentration of 0.15 μM (0.5 μM for target strand). Samples were prepared in GoTaq colourless PCR buffer with a total of 3 mM MgCl 2 at pH 8.5.
Samples were heated to 95 °C for 2 min then cooled to 30 °C. After holding at 30 °C for 1 min the samples were heated from 30 °C -95 °C with a 0.5 °C step (15 sec for first step, 5 sec per step thereafter). Fluorescence emission intensity was recorded at each step.
ESI.4.2.2 Quantum yield calculation
Quantum yields were measured in a 1 mL cuvette (Hellma quartz 'SUPRASIL QS'; 1 mL volume, 10 mm pathlength) and were measured in reference to Rh101 (QY = 1.0 at 25 °C in EtOH in range λ ex 450-565 nm) (21) . Samples were initially scanned for OD at the single wavelength of 545 nm using a Cary 50 Bio UV-Vis spectrophotometer. All samples were prepared by dissolving the fluorescent compound in MeOH (analytical grade) and then sequentially diluting with MeOH until a concentration of 0.01 ± 0.008 OD (545 nm) was reached and recorded.
Fluorescence emission measurements were made on a Perkin Elmer LS50B fluorimeter equipped with a Perkin Elmer PTP-1 Peltier system. FL Winlab Scan software was used with an emission scan range of 545-800 nm and excitation of 545 nm. Slit widths of excitation slit 3.5 nm and emission slit 4 nm were used together with a scan speed of 300 nm/min. Emission readings were taken at 25 °C and the area of each sample was calculated relative to its own baseline. Sample and reference measurements were repeated three times, with an average taken for each compound. Samples were scanned for UV absorbance from 200-800 nm (a background of buffer only was subtracted automatically from each spectrum). FRET samples were scanned for fluorescence emission from 535-800 nm (excitation 530 nm and 615 nm) with scan speed of 300 nm/min, slit widths of 15 nm excitation slit and 20 nm emission slit. Control samples were scanned with the same conditions. FRET was calculated by the equation:
FRET efficiency= (I FRET x Abs 615 )/(I direx x Abs 530 ) I FRET is the emission intensity of the Cy5 peak when excited via FRET (ex 530 nm), I direx is the emission intensity of Cy5 peak when directly excited (ex 615 nm), Abs 615 is the absorbance of the sample at 615 nm and Abs 530 is the absorbance of the sample at 530 nm.
ESI.5. Oligonucleotide data
Cy3dT and Cy5dT Oligonucleotide data
Data (for modified oligonucleotides) and sequences. 3 = Cy3dT phosphoramidite, 5 = Cy5dT phosphoramidite, p = propanol. MALDI-TOF Mass spectra (M) of oligonucleotides were recorded on a ThermoBio-Analysis Dynamo MALDI-TOF mass spectrometer in positive ion mode using oligonucleotide (oligo-dT) standards (22) or on a Bruker micrOTOF™ II focus ESI-TOF MS instrument in ES− mode (E ) as specified.
Oligonucleotide code
Sequence 
